Ömür Gökmen Sevindik

Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers

İnci Alacacıoğlu, Güner Hayri Özsan, Bahriye Payzın et al. · Chemotherapy · 2014 · 29 citations

Medicine, Hematology, Oncology +14

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Elif Birtaş Ateşoğlu, Zafer Gülbaş, Ant Uzay et al. · Hematological Oncology · 2023 · 28 citations · Full text

Medicine, Hematology, Oncology +15

Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

Şerife Solmaz, Celal Acar, Aybüke Olgun et al. · Clinical Transplantation · 2018 · 26 citations

Medicine, Hematology, Oncology +14

The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma

Şerife Solmaz, Özcan Uzun, Ömür Gökmen Sevindik et al. · International Journal of Laboratory Hematology · 2022 · 24 citations

Medicine, Hematology, Nutrition +12

A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

Aliihsan Gemici, Fahir Özkalemkaş, Mehmet Hilmi Doğu et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 23 citations · Full text

Medicine, Hematology, Oncology +12